Newly developed research grade antibodies for Epigenetics studies.
Date: 29.1.2014
Technology request: Newly developed research grade antibodies for Epigenetics studies.
Reference: 12 BE 0324 3QYV
Summary: The Epigenetics division of a Belgian global supplier of innovative solutions to academia, pharmaceutical and biotechnology companies is looking for license agreements from academic laboratories and research organisations that can provide already developed research antibodies to new target proteins.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
